Loading…
2 companies · GEL, thousands · columns ordered by revenue
| Line item | Clinic-LJ | LJ Da Ko - Tuberkulozis… |
|---|---|---|
| Total Revenue | 15,596 | 3,246 |
| Total COGS | -11,307 | -2,896 |
| Gross Profit | 4,289 | 350 |
| Gross Margin | 27.5% | 10.8% |
| Total Operating Expenses | -2,872 | -664 |
| EBITDA | 1,417 | -315 |
| EBITDA Margin | 9.1% | -9.7% |
| Total D&A | 0 | -398 |
| EBIT / Operating Income | 1,417 | -713 |
| Total Other Income | -276 | -179 |
| Profit Before Tax | 1,141 | -1,127 |
| Total Income Tax | -16 | 0 |
| Net Profit / (Loss) | 1,125 | -1,127 |
| Net Margin | 7.2% | -34.7% |
| Total Interest Expense | — | -235 |
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Clinic-LJ | Healthcare Services | 9.1% | 48th pct | 268 |
| LJ Da Ko - Tuberkulozis… | Healthcare Services | -9.7% | 13th pct | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.